Jeppesen, Ole K
464  results:
Search for persons X
?
 
?
3

Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Ad..:

Davies, Melanie ; Færch, Louise ; Jeppesen, Ole K...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A10-A11 , 2021
 
?
4

Cover Image, Volume 22, Issue 3:

Husain, Mansoor ; Bain, Stephen C. ; Jeppesen, Ole K....
Diabetes, Obesity and Metabolism.  22 (2020)  3 - p. , 2020
 
?
 
?
 
?
 
?
13

Cardiovascular safety of oral semaglutide in patients with ..:

Bain, Stephen C ; Mosenzon, Ofri ; Arechavaleta, Rosario...
Bain , S C , Mosenzon , O , Arechavaleta , R , Bogdański , P , Comlekci , A , Consoli , A , Deerochanawong , C , Dungan , K , Faingold , M C , Farkouh , M E , Franco , D R , Gram , J , Guja , C , Joshi , P , Malek , R , Merino-Torres , J F , Nauck , M A , Pedersen , S D , Sheu , W H H , Silver , R J , Tack , C J , Tandon , N , Jeppesen , O K , Strange , M , Thomsen , M & Husain , M 2019 , ' Cardiovascular safety of oral semaglutide in patients with type 2 diabetes : Rationale, design and patient baseline characteristics for the PIONEER 6 trial ' , Diabetes, Obesity and Metabolism , vol. 21 , no. 3 , pp. 499-508 . https://doi.org/10.1111/dom.13553.  , 2019
 
1-15